Navigation Links
Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
Date:2/12/2008

WOBURN, Mass., Feb. 12 /PRNewswire/ -- AdvanDx announced it has named Else Beth Trautner, a former Executive Vice President of Dako A/S, as Vice President of Sales and Marketing. Ms. Trautner will aggressively drive the global adoption of AdvanDx's fast, accurate and easy-to-use in vitro molecular diagnostic products that advance the prevention, diagnosis and treatment of infectious pathogens. Ms. Trautner previously managed an organization of more than 575 employees with annual revenues in excess of $300 million at Dako, a global cancer diagnostics company, while successfully restructuring business operations in the Asia-Pacific region that led to record sales. Ms. Trautner also orchestrated the reorganization of 22 sales subsidiaries into 5 geographic regions resulting in 15% sales growth and a 9% increase in profitability during her tenure as Executive Vice President of Global Sales at Dako.

"Ms. Trautner is a seasoned executive with proven industry experience who will drive aggressive growth, market expansion, revenue production and ultimately profitability," said Thais T. Johansen, President and CEO of AdvanDx. "The addition of Ms. Trautner clearly positions AdvanDx to deliver our easy-to-use, life saving molecular diagnostic products worldwide to help treat patients afflicted with serious infections," Mr. Johansen added.

"I am pleased to join AdvanDx's strong business and scientific management team as we make significant inroads into multi-billion dollar markets," said Else Beth Trautner, Vice President of Sales and Marketing at AdvanDx. "I look forward to ramping our success in North America while opening up new markets, seizing revenue-generating sales opportunities and further accelerating the adoption of our products in the global marketplace," said Ms. Trautner.

About AdvanDx

AdvanDx is the world's leading provider of fast, accurate and easy-to-use in vitro molecular diagnostic products that advance the prevention, diagn
'/>"/>

SOURCE AdvanDx
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Acrongenomics on Track to Acquire Molecular Vision
2. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
3. Acrongenomics Acquires Equity Stake in Molecular Vision
4. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
5. The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit
6. The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent
7. Peakdale Molecular Announces GBP 1 Million Funding to Support Expansion and Growth
8. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
9. UC Berkeley Expands Molecular Toxicology Curriculum to Include GeneGos Platform
10. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
11. Center for Molecular Medicine Among First Labs in Nation to Offer Groundbreaking Test to Aid in Treatment of Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...leEnergyCorp.announcedtodaythatthecompanyandtheOde...rded$2millionbyWashingtonState,sCommunityEconomicR...iptoconstructthestate,sfirstspecialtybiochemicalbi...willsignificantlyspeedthedevelopmentofourbiorefine...MarbleEnergyCEOKellyOgilvie."WearegratefultotheGov...
(Date:11/24/2009)...patientswithadvanced-stage,orrecurrentendometrialc...ll/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the...nendocrinetherapyandoncology,todayannouncedpositiv...xicpeptideconjugate,AEZS-108(formerlyAN-152),inpat...ersonalizedhealthcareapproach,thestudyselectedpati...
(Date:11/24/2009)...ll/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobalsp...tithassubmittedaMAAtotheEuropeanMedicinesAgencyfor...erapyindevelopment,forthetreatmentofType1Gaucherdi...ucerasealfathathasbeensubmitted,withprevious,submi...lobalsupplyshortageofthecurrentlyapprovedandmarket...
(Date:11/24/2009)...-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )toda...hairman,willpresentatthe21stAnnualPiperJaffrayHeal...009at10:00a.m.ET. ,, Toaccesstheliveandsubseque...torRelationssectionofGenomicHealth,swebsiteat http...ebsiteatleast15minutespriortothebeginningofthepres...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
...sencrance is a featured speaker at the Digital He...ic health records. With all of the new medical dis...t records, how can individual doctors master enoug...ifficult, says Michael Rosencrance. , ,Rosencrance...the University of Wisconsin Medical Foundation. He...
..., we witnessed a biotech meltdown during the first...rformance. , ,This week, we will take a look at th...se results dont include further bad news for the p...es at the end of last week when Pfizer announced t...ra) off the market. , ,This stronger-than-expected...
...e first in a new WTN series that will follow entre... For the next few weeks, we,ll focus on finalists ...have little enough time without spending inordinat...area general surgeon Michael Phillips, frustration... tissue cut out during cancer surgeries led to the...
Other Biology Technology:Michael Rosencrance deals with medical overload through human-centric IT 2Michael Rosencrance deals with medical overload through human-centric IT 3Midwest large-cap life-science sector is solid in first quarter 2Vector Surgical hopes to turn frustration into faster surgeries 2Vector Surgical hopes to turn frustration into faster surgeries 3
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlif...ort revealing that the last remaining population o...y due to the rising tide of poaching and habitat l... inform Russian officials of what needs to be done...iggest cat. , The report was releas...
(Date:11/23/2009)...INew research presents strong evidence that the "s...outdoor traffic-related pollution and indoor endot... or the other exposure alone. , Environmental ...(UC) College of Medicine have shown that children ...ticles and indoor endotoxin during early life are ...
(Date:11/23/2009)...alif. -- More than 160 participants gathered this ...k FUTURES INITIATIVE conference. This year,s topic..., engineers, and medical researchers to explore th...unding the emerging field of synthetic biology. ,...y at Princeton University and this year,s conferen...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 1University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 2University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 3Data Demonstrated ACTEMRA 28R 29 28tocilizumab 29 Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4577 1Data Demonstrated ACTEMRA 28R 29 28tocilizumab 29 Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4577 2Data Demonstrated ACTEMRA 28R 29 28tocilizumab 29 Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4577 3Data Demonstrated ACTEMRA 28R 29 28tocilizumab 29 Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4577 4Data Demonstrated ACTEMRA 28R 29 28tocilizumab 29 Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4577 5Data Demonstrated ACTEMRA 28R 29 28tocilizumab 29 Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4577 6Data Demonstrated ACTEMRA 28R 29 28tocilizumab 29 Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4577 7Data Demonstrated ACTEMRA 28R 29 28tocilizumab 29 Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4577 8Fast pandemic detection tool ready to fight flu 48386 1Fast pandemic detection tool ready to fight flu 48386 2Fast pandemic detection tool ready to fight flu 48386 3
...cial fishing causes serious fluctuations in fish p...e, says new research published today. These fluctu...ish stocks may not be sufficient to ensure their s... in today,s Nature, involved compiling the largest...ted fish off the California coast. The research te...
... from the Institut Pasteur has recently shown that...ystem in its host,s fat cells. This formidable pat...antibiotics in these cells, in which it may remain...LoS ONE, sheds new light on possible strategies fo... bacillus entirely from infected individuals shou...
...dest-known animal eggs and embryos, whose first pi...mall they looked like bugs ?which, it now appears,...ame prestigious journal presents evidence for rein...he Precambrian era as giant bacteria. , The disc...ls thought to be the oldest animals," said lead au...
Other Biology News:Commercial fishing causes dangerous fluctuations in fish populations 2Tuberculosis: The bacillus takes refuge in adipose cells 2Oldest animal fossils may have been bacteria 2
...FREEZE/THAW CYCLES. An assay kit designed to detec...estern blotting. PARP is an enzyme implicated in D... PARP is cleaved by caspase-3. Cleavage of PARP fr...poptosis. Each kit is provided with a highly speci...
...cal to the DH-2000, but comes with a shutter (cont...e DH-2000 Deuterium Tungsten Halogen Light Source... tungsten halogen light sources in a single optica...s a powerful, stable output from 215-200 nm. In ad...
Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
...rrays designed for genome-wide microRNA expression...Paraflo microfluidic on-chip synthesis platform. T...rehensive microRNA Expression Profiling Service. ...ray contains all known soil nematode microRNAs (11...
Biology Products: